Evidence map›Paper›PMID 42427168›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

The patient journey for people with dementia and their carers in Peru: From first symptoms to diagnosis and treatment.

Daniela Rossini-Vilchez, Francisco Jose Tateishi-Serruto, Christopher Butler, María Sofía Cuba-Fuentes, Silvana Perez-Leon, Miriam Lúcar-Flores, Guillermo Almeida-Huanca, L Carolina Olaya-Silva, J Jaime Miranda, Maria Kathia Cardenas and 11 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Daniela Rossini-VilchezCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Francisco Jose Tateishi-SerrutoCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Christopher ButlerDepartment of Brain Sciences, Imperial College London, London, UK.
María Sofía Cuba-FuentesCenter for Research in Primary Health Care, Universidad Peruana Cayetano Heredia, Lima, Peru.
Silvana Perez-LeonCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Miriam Lúcar-FloresHealth Economics Research Centre, University of Oxford, Oxford, UK.
Guillermo Almeida-HuancaCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
L Carolina Olaya-SilvaCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
J Jaime MirandaCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Maria Kathia CardenasCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Jose Carlos Vera TudelaCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Antonio Bernabe-OrtizCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Rafael A CalvoDyson School of Design Engineering, Imperial College London, London, UK.
Francisco Diez-CansecoCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
Filipa Trigo LandeiroHealth Economics Research Centre, University of Oxford, Oxford, UK.
Graham MooreCentre for Development, Evaluation Complexity and Implementation in Public Health Improvement (DECIPHer), School of Social Sciences, Cardiff University, Cardiff, UK.
Lee WhiteDepartment of Brain Sciences, Imperial College London, London, UK.
William WhiteleyCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
María Lazo-PorrasCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.ORCID https://orcid.org/0000-0003-0062-5476
Jemma HawkinsCentre for Development, Evaluation Complexity and Implementation in Public Health Improvement (DECIPHer), School of Social Sciences, Cardiff University, Cardiff, UK.
IMPACT Salud Research Group

Funding

Global Health NIHR150287National Institute for Health and Care Research NIHR150287
6 · The paper itself

Abstract

introductionWe explored how people with dementia (PwD) and their carers navigate Peru's health system for diagnosis and treatment.

methodsWe interviewed PwD (n = 4), carers (n = 18), and healthcare workers (n = 17) from four sites. We developed a patient journey map using thematic analysis and participant validation.

resultsThree journey stages emerged. Pre-diagnosis: Families seek care across different sub-health systems and facilities 2-4 years after symptom onset. DIAGNOSIS: Specialist consultation is sought in major cities and diagnosis occurs in hospitals based on clinical presentation. Continuity of care: Care focuses on controlling behavioral and psychological symptoms, with limited access to dementia-specific drugs and non-pharmacological interventions, and heavy reliance on carers' resources. Community mental health centers (CMHCs) are preferred facilities due to geographical and specialist accessibility and perceived care quality. DISCUSSION: Without a formal entry point to dementia care, families navigate fragmented pathways, whereas CMHCs emerge as facilities with adequate care procedures for PwD.

Indexed as

CaregiversDementiaAgedAged, 80 and overFemaleHealth Services AccessibilityHumansMaleMiddle AgedPerucaregivercomorbiditiescomorbiditydementiadiagnosisfragmented health systempatient journeyPeruquality of care

Identifiers

PMID42427168
PMCPMC13351310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.